The results of PAI-1-TFT with DSP and sctPA clearly demonstrate that the PAI-1-mechanism is a validated molecular target in both acute- [41], and chronic, advanced-stage (Figure 3) empyema modeled in rabbits. The gene discussed is DSP; the disease is empyema.